Home Physical Sciences Crystal structure of poly[1,4-bis(2-methylbenzimidazol)butane-κ2N:N′)bis(4,4′-oxybis(benzoato-κ4O,O′:O′′,O′′′)dicadmium] monohydrate, C48H38Cd2N4O10
Article Open Access

Crystal structure of poly[1,4-bis(2-methylbenzimidazol)butane-κ2N:N′)bis(4,4′-oxybis(benzoato-κ4O,O′:O′′,O′′′)dicadmium] monohydrate, C48H38Cd2N4O10

  • Chunying Xu EMAIL logo , Wenjuan Chu , Song Lei and Xuechun Yang
Published/Copyright: April 7, 2016

Abstract

C48H38Cd2N4O10, monoclinic, C2/c (no. 15), a = 22.112(4) Å, b = 9.2100(18) Å, c = 22.977(5) Å, β = 93.24(3)°, V = 4671.8(16) Å3, Z = 4, Rgt(F) = 0.0341, wRref(F2) = 0.0868, T = 293(2) K.

CCDC no.:: 1465345

A selected part of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Colorless, Blocks, Size 0.35 × 0.30 × 0.19 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:9.7 cm−1
Diffractometer, scan mode:Rigaku Saturn 724 CCD, ω
2θmax, completeness:55.8°, >99%
N(hkl)measured, N(hkl)unique:6969, 4347
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3990
N(param)refined:290
Programs:SHELX [14], Bruker programs [15]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Cd10.054823(9)0.38723(2)1.008342(9)0.03296(10)
N10.13010(12)0.2282(3)1.02595(12)0.0413(6)
N20.20242(13)0.0685(3)1.01008(14)0.0515(7)
O1−0.17599(13)−0.0664(4)0.76137(15)0.0999(13)
O2−0.01252(12)0.2631(3)0.95376(13)0.0686(8)
O3−0.08803(13)0.4199(3)0.94004(13)0.0691(8)
O40.08127(14)0.5118(3)0.92995(12)0.0744(9)
O50.00245(13)0.6579(4)0.91753(13)0.0766(9)
C10.22397(16)0.1506(4)1.05691(18)0.0535(9)
C20.27826(18)0.1497(5)1.0900(2)0.0715(13)
H20.30940.08601.08230.086*
C30.2837(2)0.2483(6)1.1352(2)0.0837(15)
H30.31950.25081.15850.100*
C40.2377(2)0.3433(5)1.1470(2)0.0753(13)
H40.24300.40671.17840.090*
C50.18433(18)0.3463(4)1.11338(17)0.0571(10)
H50.15350.41061.12140.068*
C60.17828(16)0.2502(3)1.06731(15)0.0455(8)
C70.14619(17)0.1180(3)0.99313(17)0.0482(9)
C80.10778(19)0.0515(5)0.94570(19)0.0681(11)
H8A0.0903−0.03670.95940.102*
H8B0.13200.03020.91340.102*
H8C0.07600.11770.93350.102*
C90.23644(18)−0.0481(4)0.98354(19)0.0625(11)
H9A0.2790−0.02230.98530.075*
H9B0.2230−0.05640.94280.075*
C100.22939(17)−0.1940(4)1.01264(18)0.0546(9)
H10A0.2391−0.18471.05420.066*
H10B0.1877−0.22591.00720.066*
C110.05375(18)0.6158(4)0.90615(16)0.0494(9)
C120.08393(16)0.6971(4)0.85938(15)0.0502(9)
C130.1400(2)0.6615(7)0.8431(3)0.139(3)
H130.15930.58100.86000.167*
C140.05737(17)0.8153(4)0.83260(16)0.0569(10)
H140.01880.84270.84240.068*
C15−0.06185(16)0.3034(4)0.93018(15)0.0466(8)
C16−0.09257(15)0.2021(4)0.88659(15)0.0465(8)
C17−0.1370(2)0.2523(5)0.84737(19)0.0763(14)
H17−0.14970.34830.84960.092*
C18−0.1630(2)0.1628(6)0.8048(2)0.0937(18)
H18−0.19180.19890.77740.112*
C19−0.14607(17)0.0217(5)0.80330(18)0.0695(13)
C20−0.10366(18)−0.0338(4)0.84276(18)0.0618(11)
H20−0.0932−0.13150.84170.074*
C21−0.07643(16)0.0579(4)0.88456(16)0.0503(8)
H21−0.04710.02160.91130.060*
C22−0.14178(18)−0.1433(5)0.7233(2)0.0725(13)
C23−0.1692(2)−0.2596(8)0.6977(3)0.164(4)
H23−0.2079−0.28640.70760.196*
C24−0.08605(18)−0.1043(4)0.70864(17)0.0581(10)
H24−0.0670−0.02410.72600.070*

Source of material

The title compound was prepared under the hydrothermal conditions. A mixture of 1,4-bis(2-methylbenzimidazol)butane (63.6 mg, 0.2 mmol), Cd(NO3)2·4H2O (30.8 mg, 0.1 mmol), 4,4′-oxybis(benzoic acid) (51.6 mg, 0.2 mmol), and H2O (10 mL) were placed in a Teflon-lined stainless steel vessel, heated to 130°C for 2 day, and then cooled to room temperature for 24 h. Colorless block crystals of the title complex were obtained.

Experimental details

Absorption corrections were applied by using a multi-scan program [15]. The structures were solved by direct methods and refined with the SHELXL [14] crystallographic software package. The hydrogen atoms were placed at calculated positions and refined as riding atoms fixed with isotropic displacement parameters.

Discussion

The synthesis and structural characterization of metal-organic frameworks (MOFs) have been quickly developed because of their novel structures, intriguing topologies and potential applications [14]. In particular, the great mass of organic ligands containing coordination sites of N and/or O donors are wildly utilized as designing points in the construction of MOFs [57]. Among them, the flexible N-bridging ligands bearing alkyl spacers have been wildly used to allow the ligands to bend and rotate when it coordinates to metal centers. And the flexibility of ligands is essential to forming some particular properties and structures [810]. The secondary ligands are selected to tune up the structures of complexes [11]. It is well-known that multidentate O-donor organic aromatic carboxylate ligands, such isomeric aromatic dicarboxylate ligands as phthalate (1,2-benzenedicarboxylate, 1,2-bdc), isophthalate (1,3-bdc), or terephthalate (1,4-bdc) [12], have been extensively employed in the construction of a variety of high-dimensional structures [8]. The phenyl dicarboxylate isomers contain two carboxyl groups at distinct positions, which can engender significant spatial effect and thus influence the structural assembly with multiform coordination fashions.

The title complex crystallizes in the monoclinic (C2/c) space group, which consists of one half of a 1,4-bis(2-methylbenzimidazol)butane, one 4,4′-oxybis(benzoate) one water molecule, and one Cd(II) ion in the asymmetric unit. As shown in the figure, the center Cd(II) ion is five-coordinated, ligated by four oxygen atoms (O2, O3, O4 and O5) from four symmetry-related 4,4′-oxybis(benzoate), and one nitrogen atom (N1) from 1,4-bis(2-methylbenzimidazol)butane. The bond lengths are Zn(1)—O(2) = 2.211(2) Å, Zn(1)—O(3) = 2.237(2) Å, Zn(1)—O(4) = 2.241(3) Å, Zn(1)—O(5) = 2.218(3) Å and Zn(1)—N(1) = 2.237(2) Å, respectively. They are in the normal range [13].

Acknowledgements:

This work was financially supported by the Science and technology research key project of the Education Department of Henan Province (2014A150025) and the Provincial cultivation fund of Luoyang normal university (2013-PYJJ-005).

References

1. Zhang, T.; Song, F. S.; Lin, W. B.: Blocking bimolecular activation pathways leads to different regioselectivity in metal–organic frameworks catalysis. Chem. Commun. 48 (2012) 8766–8768.10.1039/c2cc34033jSearch in Google Scholar PubMed

2. Halder, P.; Chakraborty B.; Banerjee P. R.; Zangrando E.; Paine T. K.: Role of hydroxycarboxylic acids in the construction of supramolecular assemblies of nickel(II) complexes with nitrogen donor coligands. CrystEngComm 11 (2009) 2650–2659.10.1039/b904939hSearch in Google Scholar

3. Zhao, S. N.; Song, X. Z.; Zhu, M.; Meng, X.; Wu, L. L.; Song, S. Y.; Wang, C.; Zhang, H. J.: Highly thermostable lanthanide metal-organic frameworks exhibiting unique selectivity for nitro explosives. RSC Adv. 5 (2015) 93–98.10.1039/C4RA13773FSearch in Google Scholar

4. Furukawa, H.; Cordova, K. E.; O'Keeffe, M.; Yaghi, O. M.: The chemistry and applications of Metal-Organic Frameworks. Science 341 (2013) 1230444, 12 pages.10.1126/science.1230444Search in Google Scholar PubMed

5. Meng, X.; Song, S. Y.; Song, X. Z.; Zhu, M.; Zhao, S. N.; Wu, L. L.; Zhang, H. J.: A Eu/Tb-codoped coordination polymer luminescent thermometer. Inorg. Chem. Front. 1 (2014) 757–760.10.1039/C4QI00122BSearch in Google Scholar

6. Yang, H. X.; Liang, Z.; Hao, B. L.; Meng, X. R.: Syntheses, crystal structures, and characterization of three 1D, 2D and 3D complexes based on mixed multidentate N and O-donor ligands. J. Solid State Chem. 218 (2014) 23–31.10.1016/j.jssc.2014.06.003Search in Google Scholar

7. Ma, L. F.; Wang, L. Y.; Wang, Y. Y.; Batten, S. R.; Wang, J. G.: Self-Assembly of a series of cobalt(II) coordination polymers constructed from H2tbip and dipyridyl-based ligands. Inorg. Chem. 48 (2009) 915–924.10.1021/ic801278jSearch in Google Scholar PubMed

8. Liu, T.; Luo, D.; Xu, D.; Zenga, H.; Lin, Z.: An open-framework rutile-type magnesium isonicotinate and its structural analogue with an anatase topology. Dalton Trans. 42 (2013) 368–371.10.1039/C2DT31394DSearch in Google Scholar PubMed

9. Feng, X.; Wang, L.-Y.; Wang, J.-G.; Xie, C.-Z.; Zhao, J.-S.; Sun, Q.: A unique example of a 3D framework based on the binuclear dysprosium(III) azobenzene-3,5,4′-tricarboxylate with 3,6-connected topology showing ferromagnetic properties. CrystEngComm 12 (2010) 3476–3482.10.1039/c0ce00119hSearch in Google Scholar

10. Xin, L. Y.; Li, X. L.; Liu, G. Z.; Guo, H.: Two distinct 2D Cd(II)/Zn(II) networks based on flexible 1,2-phenylenediacetate and N-donor co-ligand: Synthesis, structure, and fluorescent properties. Synth. React. Inorg. Metal-Org. nano-Met. Chem. 43 (2013) 196–202.10.1080/15533174.2012.740710Search in Google Scholar

11. Bai, H. Y.; Ma, J. F.; Yang, J.; Zhang, L. P.; Ma, J. C.; Liu, Y. Y.: Eight two-dimensional and three-dimensional metal-organic frameworks based on a flexible tetrakis(imidazole) ligand: synthesis, topological structures, and photoluminescent properties. Cryst. Growth Des. 10 (2010) 1946–1959.10.1021/cg100032nSearch in Google Scholar

12. Xin, L. Y.; Liu, G. Z.; Ma, L. F.; Zhang, X.; Wang, L. Y.: Structural diversity and fluorescence regulation of three ZnII coordination polymers assembled from mixed ligands tectons. Aust. J. Chem. 68 (2015) 758–765.10.1071/CH14347Search in Google Scholar

13. Li, B. Y.; Yang, F.; Li, G. H.; Liu, D.; Zhou, Q.; Shi, Z.; Feng, S. H.: Construction of coordination polymers based on bent 4-amino-3,5-bis(3-carboxyphenyl)-1,2,4-triazole ligand: diverse structural topology and photoluminescent and magnetic properties. Cryst. Growth Des. 11 (2011) 1475–1485.10.1021/cg101335aSearch in Google Scholar

14. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

15. Brucker. APEX2 , SAINT and SADABS. Brucker AXS Inc., Madison, Wisconsin, USA, 2009.Search in Google Scholar

Received: 2016-1-3
Accepted: 2016-3-14
Published Online: 2016-4-7
Published in Print: 2016-9-1

©2016 Chunying Xu et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of poly[aqua(μ2-2,5-bis(4-pyridyl)-1,3,4-oxadiazole-κ2N,N)(μ2-1,3-phenylenediacetato-κ3O,O′:O′′)cobalt(II)], C22H18CoN4O6
  3. Crystal structure of 2-amino-7,7-dimethyl-5-oxo-4-(3-phenoxy-phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
  4. Crystal structure of (E)-4,4′-(diazene-1,2-diyl)bis(1-nitro-1H-1,2,4-triazol-5(4H)-one)—acetonitrile (1:1), C6H5N11O6
  5. Crystal structure of potassium (E)-5-oxo-4-((5-oxo-1H-1,2,4-triazol-4(5H)-yl)diazenyl)-4,5-dihydro-1,2,4-triazol-1-ide – (E)-4,4-diazene-1,2-diylbis(2,4-dihydro-3H-1,2,4-triazol-3-one) – methanol (1/1/1), C9H11N16KO5
  6. Crystal structure of (N,N′-bis(2-(((2,6-diisopropylphenyl)imino)methyl)phenyl)benzene-1,2-diamido-κ4O,O′,O′′,O′′′)oxidovanadium(IV), C44H48N4OV
  7. Crystal structure of 5,5-bis(4-iodophenyl)-5H-cyclopenta[2,1-b:3,4-b′]dipyridine, C23H14I2N2
  8. Crystal structure of aquadichloridobis(1-((2-methyl-1H-imidazol-1-yl)methyl)-1H-benotriazole-κN)mercury(II), C22H24Cl2HgN10O
  9. Crystal structure of 2-[4-(1H-imidazol-1-yl)phenyl]-1H-benzimidazol-3-ium [2-(carboxymethyl)phenyl]acetate monohydrate, C26H24N4O5
  10. Crystal structure of 4,4′-bipiperidinium dichloride 0.12 hydrate, C10H22N2Cl2 · 0.12 H2O
  11. Crystal structure of catena-poly[tetraaqua(μ2-4,4′(E)-ethene-1,2-diyldipyridine-κ2N:N′)nickel(II)] bis(6-methyl-2-oxo-1,2-dihydro-pyridine-4-carboxylate) pentahydrate, C26H42N4O15Ni
  12. Crystal structure of ethyl-5-amino-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carboxylate, C12H11N5O6
  13. Crystal structure of dicarbonyl(pyridin-2-olate-1-oxido-κ2O,O′)rhodium(I), C7H4NO4Rh
  14. Crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)thiourea, C17H21ClN2S
  15. Crystal structure of 2-((2-chloropyridin-3-ylamino)methylene)malononitrile, C9H5ClN4
  16. Crystal structure of tetraaquabis(μ2-4-chlorobenzoato-κ2O:O,O′)bis(4-chlorobenzoato-κO)bis(1,10-phenanthroline-κ2N,N′)distrontium(II), C52H40Cl4N4O12Sr2
  17. Crystal structure of 3-hydroxy-3-phenyl-1,3-dihydro-2H-indol-2-one, C14H11NO2
  18. Crystal structures of bis(1,10-phenanthrolin-1-ium) aquapentakis(nitrato-κ2O,O′)neodym(III) monohydrate, C24H22N9NdO17
  19. Crystal structure of 2-ethyl-1-tert-butyl 3-oxo-2-[phenyl(tert-butoxycarbonylamino)methyl]-1,2-pyrrolidinedicarboxylate, C24H34N2O7
  20. Crystal structure of poly[diaquabis(μ4-benzene-1,3,5-tricarboxylato-κO1O2O3O4O5O6)-bis(μ2-4,4′-benzene-1,3-diylbis(4H-1,2,4-triazole-κ2N:N′)tricadmium(II)] tetrahydrate, C38H34Cd3N12O18
  21. Crystal structure of trans-dichlorido[1,3-bis(9-methyl-9H-fluoren-9-yl) benzimidazol-2-ylidene](pyridine)palladium(II) – a compound with anagostic CH–Pd interactions, C40H31Cl2N3Pd
  22. Crystal structure of catena-poly[(μ3-5-(4-(tetrazol-1-id-5-yl)phenoxy)benzene-1,3-dicarboxyato-κ3O:O′:N)(4-(3-(pyridin-4-yl)propyl)pyridinium-κN)zinc(II)], C28H22ZnN6O5
  23. Crystal structure of 3,6-di-2-pyridinyl-4-pyridazine carbonitrile, C15H9N5
  24. Crystal structure of 5,5,9,13-tetramethyltetracyclo[10·2·1·01,10·04,9]pentadecane-3,7,14-triol, C20H34O4
  25. Crystal structure of 2-amino-7-methyl-5-oxo-4-phenyl-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C16H12N2O3
  26. Crystal structure of the poly[(1,10-phenanthroline-κ2N,N′)(μ3-carboxylatophenoxyacetato-κ4O,O′:O′′;O′′′)lead(II)] monohydrate, C21H16N2O6Pb
  27. Crystal structure of the poly[(μ4-biphenyl-4,4′-dicarboxylato-κ4O:O′:O′′:O′′′) bis(μ3-8-(11-(oxysulfonyl)-4-silbenyl)-2-(oxysulfonyl)stilbene-κ4O:O′:O′′,O′′′) bis(1,10-phenanthroline-k2N,N′) dipraseodymium(III)], C94H64N4O16Pr2S4
  28. Crystal structure of 3-iodo-5-methoxy-7-(methoxymethoxy)-4-(3-methoxyphenoxy)-2H-chromen-2-one, C19H17IO7
  29. Crystal structure of poly[(5-carboxy-2,6-dimethylpyridinium-3-carboxylato-κO)tris(μ2-2,6-dimethylpyridinium-3,5-dicarboxylato-κ3O,O′:O′′)erbium(III)], C36H33ErN4O16
  30. This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
  31. Crystal structure of poly[(μ2-2,2′-benzene-1,2-diyldiacetato-κ2O:O′), (μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)zinc(II)], C22H19N5O4Zn
  32. Crystal structure of tetraaqua(μ2-3-(3,5-dicarboxyphenoxy)benzene-1,2-dicarboxylato-κ2O:O′)manganese(II) dihydrate, C16H20O15Mn
  33. Crystal structure of 4,4′-sulfonyldipyridine, C10H8N2O2S
  34. Crystal structure of 4-[(E)-(2-chloro-6-fluorobenzylidene)amino]-1,2-dihydro-2,3-dimethyl-1-phenylpyrazol-5-one, C18H15ClFN3O
  35. Crystal structure of carbonyl(2-oxopyridin-1(2H)-olato-κ2O, O′)(triphenylphosphine-κP)rhodium(I), C24H19NO3PRh
  36. Crystal structure of diaquabis(2-(3-bromophenyl)-5-carboxy-1H-imidazol-4-carboxylato-κ2O,N) cobalt(II) trihydrate, C22H22Br2CoN4O13
  37. Crystal structure of 4-(pyridin-4-ylmethylsulfonyl)pyridine, C11H10N2O2S
  38. Crystal structure of poly[(μ4-1-methyl-1H-tetrazole-5-thiolato-κ3S:S:N:N′)copper(I)], C2H3CuN4S
  39. Crystal structure of poly[diaquabis(μ2-4,4′-sulfinyldipyridine-κ2N,N′)zinc(II)] diperchlorate dihydrate, C20H24N4O14S2Cl2Zn
  40. Crystal structure of (1-((1-benzylpyrrolidin-2-yl-κN)methyl)-3-isopropyl-1H-imidazol-2(3H)-ylidene–κC)dibromidopalladium(II), C18H25Br2N3Pd
  41. Crystal structure of pentacalcium tetranitridovanadate(V) mononitride based on a powder diffraction study, Ca5[VN4]N
  42. Crystal structure of ((1-((1-benzylpyrrolidin-2-yl)methyl)-3-ethyl-1H-imidazol-2(3H)-ylidene)-κ2C,N)dichloridopalladium(II), C17H23Cl2N3Pd
  43. Crystal structure of 9-allyl-4,5-dichloro-12-cyano-9,10-dihydro-9,10-ethanoanthracen-12-yl acetate, C22H17Cl2NO2
  44. Crystal structure of 4-bromo-2-(8-(3-ethoxy-2-hydroxyphenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenol, C18H19BrN2O5
  45. Crystal structure of 3-tert-butyl-3-hydroxy-1,3-dihydro-2H-pyrrolo[3,2-c]pyridin-2-one, C11H14N2O2
  46. Crystal structure of diaquabis(3-(3,5-dibromophenyl)-5-(pyridin-2-yl)-1,2,4-triazol-4-ido-κ2N,N′)nickel(II) mono hydrate, C26H20Br4N8NiO3
  47. Crystal structure of 5-(adamantan-1-yl)-3-[(2-trifluoromethylanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione, C20H22F3N3OS
  48. Crystal structure of 2-ethyl-1-tert-butyl-2-((4-fluorophenyl)(tert-butoxycarbonylamino)methyl)-3-oxo-pyrrolidine-1,2-dicarboxylate, C24H33FN2O7
  49. Crystal structure of bis(μ2-2-fluorobenzoato-κ2O:O:O′) bis(μ2-2-fluorobenzoato-κ2O:O′)dinitrato-κ2O,O′ bis(1,10-phenathroline-κ2N,N′)diterbium(III), C52H32F4N6O14Tb2
  50. Crystal structure of tetrabutylammonium 4-aminobenzenesulfonate 2/3 hydrate, C22H42N2O3S · 2/3 H2O
  51. Crystal structure of tetraethylammonium 4-aminobenzenesulfonate, C14H26N2O3S
  52. Crystal structure of bis(guanidinium) 3,3′-oxybis(6-carboxybenzoate), C18H20N6O9
  53. Crystal structure of N′-(4-methoxybenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C18H16N4O2
  54. Crystal structure of N′-(4-nitrobenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C17H13N5O3
  55. Crystal structure of 5-((4-bromophenyl)(2-hydroxy-6-oxocyclohex-1-en-1-yl)methyl)-6-hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, C19H19BrN2O5
  56. Crystal structure of 3-(((cyclohexyl(phenyl)methylidene)amino)oxy)-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride, C19H31ClN2O2
  57. Crystal structure of 6-hydroxy-5-((2-hydroxy-6-oxocyclohex-1-en-1-yl)(phenyl)methyl)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, C19H20N2O5
  58. Crystal structure of 2-(4-(4-bromophenyl)thiazol-2-yl)isoindoline-1,3-dione, C17H9BrN2O2S
  59. Crystal structure of 2-(4-methylbenzoyl)pyrene, C24H16O
  60. Crystal structure of N-(5-bromo-4-(p-tolyl)thiazol-2-yl)-4-chlorobutanamide, C14H14BrClN2OS
  61. Crystal structure of 4,5-diphenylthiazol-2-amine, C15H12N2S
  62. Crystal structure of poly[bis(μ2-4-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzoato-κ3N:O,O′)-lead(II)], C28H18O4N8Pb
  63. Crystal structure of (Z)-4-(4-oxopent-2-en-2-ylamino)benzenesulfonamide, C11H14N2O3S
  64. Crystal structure of poly[(μ2-2-methyl-1-(4-(2-methyl-2H-benzo[d] imidazol-1(7aH)-yl)butyl)-1H-benzo[d]imidazole-κ2N:N′)bis(μ3-5-tert-butylbenzene-1,3-dicarboxylato-κ4O:O,O′:O′′,O′′′)dicadmium(II)] tetrahydrate, C44H54Cd2N4O12
  65. Crystal structure of catena-poly-[aqua(μ2-4,4′-bipyridine-κ2N:N′)bis(3′,5,5′-tricarboxybiphenyl-2-carboxylato-κ2O,O′)cadmium(II)], C42H28N2O17Cd
  66. Crystal structure of (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol, C15H20ClN3O
  67. Crystal structure of N′-(4-(dimethylamino)benzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C19H19N5O
  68. Crystal structure of 3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1Hpyrazole-1-carbothioamide, C18H14FN3OS
  69. Crystal structure of ent-1β-acetoxy-7α,14α-di-hydroxy-7β,20-epoxykaur-16-en-15-one, C22H30O6
  70. Crystal structure of 1α,7β-dihydroxy-11β-acetoxy-ent-7β,20-epoxykaur-16-en-15-one, C22H30O6
  71. Crystal structure of 7β,14β,15β-trihydroxy-1α-acetoxy-7α,20-epoxy-ent-kaurane, C22H32O6
  72. Crystal structure of ent-1β,7α,11α-trihydroxy-7β,20-epoxykaur-16-en-15-one, C20H28O5
  73. Crystal structure of poly-[tetraaquabis(μ8-benzene-1,2,4,5-tetracarboxylato-1κ3O4:O6:O8:2κ4O2:O2:O5:O5:3κ4O1:O3:O5:O7)(di-μ3-hydroxido)-pentazinc(II)] decahydrate, C20H34O32Zn5
  74. Crystal structure of 1-(4-methylthiazol-2-yl)-3-propylthiourea, C8H13N3S2
  75. Crystal structure of 2-((dimethylamino)methylene)-5,5-Dimethylcyclohexane-1,3-dione, C11H17NO2
  76. Crystal structure of poly[1,4-bis(2-methylbenzimidazol)butane-κ2N:N′)bis(4,4′-oxybis(benzoato-κ4O,O′:O′′,O′′′)dicadmium] monohydrate, C48H38Cd2N4O10
  77. Crystal structure of 2-(3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-(4-chlorophenyl)thiazole, C26H17ClFN3OS
  78. Crystal structure of bis(μ3-isophthalato-κ3O:O′:O′′)(μ2-1,4-\ bis((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)dizinc(II), C22H19N2O4Zn
  79. Crystal structure of poly[bis(adipate-κ4O,O′:O′′, O′′′)(1,4-bis(2-methyl-1H-benzo[d]imidazol-1-yl)benzene-κ2N:N′)dizinc(II), C36H38N4O8Zn2
  80. Crystal structure of N-(2-(2-oxoindolin-4-yl)ethyl)-N-propylpropan-1-aminium tetraphenylborate, C40H45BN2O
  81. Crystal structure of 1-(2,3-dihydro-4-methyl-3-phenyl-2-thioxothiazol-5-yl)-1-ethanone, C12H11NOS2
  82. Crystal structure of 3-(adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(E)-(2,6-difluorobenzylidene)amino]-1H-1,2,4-triazole-5(4H)-thione, C31H36F2N6S
  83. Crystal structure of 6-(4-chlorophenyl)-3-(thiophen-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole, C13H7ClN4S2
  84. Crystal structure of bis(ethanaminium) poly[bis(hexaselenido-κ2Se1,Se6)palladate(II)], C4H16N2PdSe12
  85. Crystal structure of 2-(3-(benzofuran-2-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazole, C26H19N3OS
  86. Crystal structure of poly-[bis(μ3-5-hydroxyisophtalato-κ3O:O′:O′′)(μ2-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)dizinc(II)], C40H30N4O5Zn2
  87. Crystal structure of poly-[(μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ4-2,2′-(1,3-phenylene)diacetate-κ4O:O′:O′′:O′′′)dizinc(II)], C44H38N4O8Zn2
  88. Crystal structure of 5,17-bis-cyano-25,26,27,28-tetrapropyloxy-calix[4]arene, C42H46N2O4
  89. Crystal structure of poly-[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ3-5-hydroxyisophthalate(2–)-κ3O,O′:O′′)dicadmium(II)] monohydrate, C64H54N8O11Cd2
  90. Crystal structure of poly-[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ4-4,4′-sulfonyldibenzoato-κ4O:O′:O′′:O′′′)dicadmium(II)] monohydrate, C52H42N4O14Cd2
  91. Crystal structure of poly-[bis(μ4-adipato-κ4O:O′:O′′:O′′′)(μ2-1,4-bis((2-ethyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)dizinc(II)], C38H42N4O8Zn2
  92. Crystal structure of (2-(2-chlorophenyl)-5-methyl-1,3-dioxan-5-yl)methanol, C12H15ClO3
  93. Crystal structure of 2-(4-Bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylic acid, C13H15BrO4
  94. Crystal structure of (2-(4-bromophenyl)-5-ethyl-1,3-dioxan-5-yl)methanol, C13H17BrO3
  95. Crystal structure of 3-((1,3,5,7-tetraoxo-6-(pyridin-3-ylmethyl)-3,3a,4,4a,5,6,7,7a,8,8a-decahydro-4,8-ethenopyrrolo[3,4-f]isoindol-2(1H)-yl)methyl)pyridin-1-ium-κN-trichloridocobalt(II) hemihydrate, C24H22Cl3CoN4O4.5
  96. Crystal structure of 4-chloro-4′,6′-dichloro-2,2′-[propane-1,3-diyldioxybis(nitrilomethylidyne)]-diphenol, C17H14Cl3N2O4
  97. Crystal structure of 2-amino-4-(3-trifluoromethylphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H13F3N2O2
  98. Crystal structure of bis(benzoato-κO)bis(4,4′-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile-κN)zinc(II), C48H32N10O4Zn
  99. Crystal structure of 3-methyl-2H-chromen-2-one, C10H8O2
  100. Crystal structure of catena-poly-[aqua-(2-carboxy-5-(3-carboxy-5-carboxylatophenoxy)benzoato-κO)(μ2-4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-κ2N:N′)cobalt(II)], C34H24N4O10Co
  101. Crystal structure of 4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl, C36H28N8
  102. Crystal structure of 1-(3-chloropropyl)piperidin-1-ium tetraphenylborate, C32H37BClN
  103. Crystal structure of dimethyl 5-(benzylamino)isophthalate, C17H17NO4
  104. Crystal structure of dimethyl 5-(dibenzylamino)isophthalate, C24H23NO4
  105. Crystal structure of N-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioamide, C21H29N3S
  106. Crystal structure of (2,2′(cyclohexane-1,2-diylbis(nitrilo(E)methylylidene))diphenolato-κ4O,O′,N,N′)dimethanolmanganese(III) bromide, C22H28BrMnN2O4
  107. Crystal structure of 3,5,7-tris(morpholinomethyl)tropolone·0.67 hydrate, C22H33N3O5·0.67H2O
  108. Crystal structure of biphenyl-2,3′,5,5′-tetracarboxylic acid – 4,4′-biphenyl-4,4′-diyldipyridine (3/2), C49H34N3O8
Downloaded on 20.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0003/html
Scroll to top button